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Transepithelial migration of neutrophils
into the lung requires TREM-1
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Sankar Baruah,1 David K. Meyerholz,3 Steven M. Varga,4 Cory J. Knudson,4
Thomas O. Moninger,5 Jessica Moreland,6 Joseph Zabner,1 and Marco Colonna2
1Department

of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. 2Department of Pathology,
Washington University in St. Louis, St. Louis, Missouri, USA. 3Department of Pathology, 4Department of Microbiology,
5Central Microscopy Research Facility, and 6Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

Acute respiratory infections are responsible for more than 4 million deaths each year. Neutrophils play an
essential role in the innate immune response to lung infection. These cells have an armamentarium of pattern
recognition molecules and antimicrobial agents that identify and eliminate pathogens. In the setting of infection, neutrophil triggering receptor expressed on myeloid cells 1 (TREM-1) amplifies inflammatory signaling.
Here we demonstrate for the first time that TREM-1 also plays an important role in transepithelial migration of neutrophils into the airspace. We developed a TREM-1/3–deficient mouse model of pneumonia and
found that absence of TREM-1/3 markedly increased mortality following Pseudomonas aeruginosa challenge.
Unexpectedly, TREM-1/3 deficiency resulted in increased local and systemic cytokine production. TREM-1/3–
deficient neutrophils demonstrated intact bacterial killing, phagocytosis, and chemotaxis; however, histologic examination of TREM-1/3–deficient lungs revealed decreased neutrophil infiltration of the airways.
TREM-1/3–deficient neutrophils effectively migrated across primary endothelial cell monolayers but failed
to migrate across primary airway epithelia grown at the air-liquid interface. These data define a new function
for TREM-1 in neutrophil migration across airway epithelial cells and suggest that it amplifies inflammation
through targeted neutrophil migration into the lung.
Introduction
Acute respiratory infections have been described as the forgotten pandemic, responsible for 4.5 million deaths annually. Effective neutrophil migration into the intrapulmonary airspace is
essential for pathogen elimination in the lung. Neutrophils possess diverse tools, including ROS intermediates, antimicrobial
peptides, neutrophil extracellular traps, and numerous pattern
recognition receptors (PRRs), that facilitate the response to de
novo infections (1, 2). Moreover, neutrophils participate in B cell
maturation and differentiation, Th17 responses, dendritic cell
maturation, natural killer cell responses, and IL-10 production,
revealing a regulatory role for neutrophils (2). Like other cells
of the innate immune system, neutrophils express several large
genetically encoded receptor families that act to detect and eliminate pathogens. These families include the TLR family, C-type
lectin receptors, and the triggering receptor expressed on myeloid
cells (TREM) family (3–5).
TREM-1, which was initially discovered on human neutrophils
and monocytes, has been studied in patients with pneumonia and
sepsis (6, 7). Increased TREM-1 levels in bronchoalveolar lavage
(BAL) fluid strongly correlate with ventilator-associated pneumonia, and systemic levels of TREM-1 in the serum serve as a marker
of sepsis (8, 9). TREM-1 has been shown to amplify the inflammatory cascade in response to infection (10). Surface expression
of TREM-1 is increased in response to LPS and other microbial
products in vitro. Antibody-mediated crosslinking of TREM-1
induces modest cellular activation and proinflammatory cytokine
secretion. Furthermore, when TREM-1 acts in concert with PRRs,
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there is a synergistic increase in inflammatory signaling (10–13).
Such data suggest that TREM-1 functions as an amplifier of the
immune response in the context of microbial infection.
During the process of pathogen recognition and elimination,
excessive cytokine and chemokine release can lead to extensive tissue damage and even death (14, 15). Therapeutic agents designed to
temper the deleterious consequences of host-pathogen interactions
result in a survival benefit in some experimental models of endotoxemia. On the other hand, it is clear that some inflammation is
necessary for bacterial killing in vivo. Accordingly, numerous clinical examples of impaired neutrophil function are linked to increased
rates of infection and death, including chronic granulomatous disease (CGD), neutropenic fever, and lymphocyte adhesion deficiency.
However, animal studies indicate that effective bacterial clearance can
be achieved in the setting of decreased inflammation (16, 17). In the
case of TREM-1, blockade of TREM-1 has been achieved by administering soluble forms of TREM-1, small molecule blocker (LP-17),
or RNA silencing (10, 18, 19). All three of these interventions result
in decreased systemic cytokine production and improved survival
in mice. Taken together, these animal studies of TREM-1 blockade
suggest that it may be possible to modulate the TREM-1 pathway to
decrease inflammation without sacrificing bacterial control.
We hypothesized that TREM-1 deficiency would decrease
inflammation and improve survival in a murine pneumonia
model. Paradoxically, we found that TREM-1/3 deficiency resulted
in a marked increase in mortality. Our data suggest that impaired
neutrophil transepithelial migration is the mechanism underlying
the failure to clear lung bacteria, resulting in increased mortality
with TREM-1/3 deficiency. These findings identify a novel role for
TREM-1 in neutrophil epithelial transmigration in addition to its
established role in amplifying inflammatory signaling.
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Figure 1
TREM-1/3 expression is essential for host survival following P. aeruginosa challenge. (A) Kaplan-Meier survival plot of TREM-1/3–deficient
(n = 35, 4 experiments) and WT mice (n = 26, 4 independent experiments) following intratracheal challenge with P. aeruginosa (*P = 0.0001).
(B) Body temperature was measured 14 hours after infection with P. aeruginosa (*P = 0.0001) (n = 95 mice, 9 experiments). (C) As a marker of
liver damage, ALT levels were measured 14 hours after intratracheal challenge with P. aeruginosa (n = 11).

Results
Generation of TREM-1–deficient mice. The goal of these studies was
to elucidate the role of TREM-1 in pneumonia using a mouse
model of TREM-1 deficiency. In mice, the Trem1 gene is adjacent
to a highly homologous gene, Trem3, which likely arose from a
duplication event. The two receptors have similar cellular distribution and associate with DAP12. Further suggesting that these
two proteins have redundant functions in the mouse, functional
studies in our laboratory and others show that both molecules
are amplifiers of inflammatory signaling (20). In contrast, Trem3
is a pseudogene in humans, and therefore no functional overlap
exists. Thus, to model the effect of blocking TREM-1 in humans,
we generated a TREM-1/3–deficient mouse. To abrogate expression of functional TREM-1 and TREM-3 proteins, we made a
targeting construct in which an 8.8-kb fragment containing
most of exon 3 and exon 4 of Trem1 as well as exon 1 of Trem3
was replaced with a MC1neopA gene flanked by loxP sites (Supplemental Figure 1; supplemental material available online with
this article; doi:10.1172/JCI64181DS1). This effectively deleted
the transmembrane region of TREM-1 in addition to the start
site and first domain of TREM-3. Chimeras generated from a
correctly targeted clone were bred to transgenic mice expressing Cre under the CMV promoter on a C57BL/6 background to
delete the MC1neopA gene. Homozygote TREM-1/3–deficient
mice failed to express TREM-1 and TREM-3 proteins (Supplemental Figure 2). Inheritance of this mutation followed expected Mendelian distribution, with 25% homozygotes, 21% WT,
and 54% heterozygotes assayed (n = 229). Flow cytometric analysis using lineage markers revealed no significant differences in

the percentages of circulating leukocyte populations as a result
of Trem1 and Trem3 deletion (Supplemental Figure 3).
TREM-1/3 is essential for host survival following pulmonary challenge with
P. aeruginosa. To examine the role of TREM-1 in survival in response
to pneumonia, we challenged TREM-1/3–deficient mice, WT littermate controls, or WT C57BL/6 mice intratracheally with P. aeruginosa. Survival analysis performed using Gehan-Breslow-Wilcoxon
statistical tests showed a significant increase in mortality in TREM1/3–deficient mice as compared with WT mice, with χ2 = 18.75
and P < 0.0001 (Figure 1A). Additional clinical indicators of sepsis
including body temperature and evidence of end-organ damage
were monitored. TREM-1/3–deficient animals were hypothermic
(Figure 1B, P = 0.0001), consistent with the development of systemic disease. TREM-1/3–deficient animals also showed evidence
of end-organ damage in the form of transaminitis as measured by
serum alanine aminotransferase (ALT) levels, whereas WT animals
had no elevation (Figure 1C). These data indicate that TREM-1/3
expression is essential for host survival following pulmonary chal-

Figure 2
TREM-1/3–deficient mice fail to eradicate P. aeruginosa following pulmonary challenge. (A) CFU of P. aeruginosa in BAL fluid at 4 hours after
infection in WT and TREM-1/3–deficient mice (n = 12, 1 experiment).
(B) CFU of P. aeruginosa in BAL from WT and TREM-1/3–deficient
mice 14 hours after infection (*P = 0.011) (n = 27, 2 independent experiments). (C) CFU of P. aeruginosa recovered in whole lung homogenates
from WT and TREM-1/3–deficient mice 14 hours after infection
(*P = 0.036) (n = 14, 1 experiment). (D) CFU of P. aeruginosa recovered from cardiac puncture 14 hours after inoculation in TREM-1/3–
deficient and WT mice (n = 27, 2 independent experiments).
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Figure 3
TREM-1/3–deficient neutrophils effectively kill P. aeruginosa. (A) TREM-1/3–deficient and WT neutrophil phagocytosis of Texas red–labeled zymosan particles was quantitated as the percentage of cells ingesting particles (2 independent experiments; pooled neutrophils from 2–3 mice per
group). (B) The relative number of Texas red–labeled particles ingested per neutrophil was also quantified using the geometric MF of Texas red–
positive TREM-1/3–deficient and WT neutrophils. (C) The ability of TREM-1/3–deficient and WT bone marrow neutrophils to kill P. aeruginosa was
measured (3 independent experiments; pooled neutrophils from 2–3 mice per group).

lenge with P. aeruginosa. Challenge with heat-killed P. aeruginosa
resulted in no mortality in WT or TREM-1/3–deficient mice (n = 4
in each group, data not shown), suggesting that the difference in
survival observed in the TREM-1/3–deficient mice was due to a
decrease in the ability to control active infection and not increased
inflammation in the setting of endotoxin challenge.
TREM-1/3–deficient animals fail to eradicate P. aeruginosa. To assess
bacterial clearance, we performed bacterial sampling of BAL
fluid using whole lung lavage on anesthetized animals at either
4 or 14 hours after infection. At 4 hours after infection, both
TREM-1/3–deficient and WT BAL fluid (Figure 2A) showed
growth of P. aeruginosa. However, at 14 hours after infection,
P. aeruginosa CFU were higher in the lungs of TREM-1/3–deficient
animals (Figure 2B, P = 0.011). In addition, P. aeruginosa CFU were
also significantly higher in cultures obtained from whole lung
suspensions generated 14 hours after infection in TREM-1/3–
deficient as compared with WT mice (Figure 2C, P = 0.036). Next,
blood was obtained by cardiac puncture 14 hours after infection
to assess systemic bacteremia (Figure 2D). TREM-1/3–deficient
animals had a higher incidence of bacteremia (53% TREM-1/3–
deficient vs. 27% WT). Thus, TREM-1/3–deficient mice fail to
eradicate P. aeruginosa infection locally, resulting in systemic dissemination of bacteria and death.
TREM-1/3–deficient neutrophils kill P. aeruginosa effectively in vitro.
To assess whether impaired neutrophil function was the mechanism for poor local and systemic control of P. aeruginosa in the
TREM-1/3–deficient animals, we measured phagocytosis and in
vitro neutrophil killing of P. aeruginosa. First, phagocytosis was
measured using Texas red–zymosan. Neutrophils were isolated
from TREM-1/3–deficient and WT bone marrow (pooled 3–5 per

group). There were no significant differences in the percentage of
neutrophils that ingested particles (Figure 3A) or in the number
of particles phagocytized per neutrophil as determined by the
geometric mean of Ly6G-positive cells (Figure 3B). To distinguish
between intracellular and extracellular particles, we performed

Figure 4
TREM-1/3–deficient mice have decreased histologic evidence of pneumonia following P. aeruginosa challenge. (A and B) Representative
H&E-stained lungs from (A) WT or (B) TREM-1/3–deficient mice 14
hours after infection with P. aeruginosa. Original magnification, ×10;
inset, ×60. Arrows indicate areas of necropurulent foci. ×10 scale bar:
140 μm; ×60 scale bar: 50 μm. (C) Leukocyte infiltration score in lungs
from WT and TREM-1/3–deficient mice 14 hours after infection (n = 10
mice, *P = 0.016). (D) Necrotic foci score in lungs of WT and TREM-1/3–
deficient mice 14 hours after infection (n = 10 mice, *P = 0.05). Error
bars indicate SEM.
140

The Journal of Clinical Investigation    http://www.jci.org   Volume 123   Number 1   January 2013

Downloaded on October 19, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/64181

research article

Figure 5
Quantification of neutrophils in lung compartments following P. aeruginosa challenge. (A) Quantification of total wbc populations in single-cell
suspensions from lungs of WT and TREM-1/3–deficient mice 14 hours after infection (n = 15, *P = 0.001). (B) Quantification of neutrophils present
in BAL of WT and TREM-1/3–deficient mice 14 hours after infection (n = 20, *P = 0.004, 2 independent experiments) (C) Morphometric analysis of
the neutrophils in the interstitium of terminal bronchioles from the lungs of WT and TREM-1/3–deficient mice (n = 14, *P = 0.001). (D) Stereotactic
analysis of alveolar neutrophils from the lungs of WT and TREM-1/3–deficient animals (n = 14, P = 0.79). Error bars indicate SEM.

fluorescence quenching with trypan blue (21). No significant difference in quenching was detected between WT and TREM-1/3–
deficient neutrophils (Supplemental Figure 4). Next, to examine
the capacity of murine neutrophils to kill P. aeruginosa, we isolated
neutrophils and co-incubated them with bacteria (22). At 30 minutes, more than 90% of the bacteria were ingested. Non-ingested
bacteria were killed with gentamicin, as previously described (23).
Intracellular bacterial killing was assessed at 30, 60, and 90 minutes after exposure to gentamicin. There was no significant difference in the ability of TREM-1/3–deficient and WT neutrophils to
kill P. aeruginosa (Figure 3C). Finally, to determine how TREM-1/3
deficiency affects neutrophil ROS production, we isolated neutrophils from WT and TREM-1/3–deficient animals and stimulated
them with opsonized zymosan and PMA. In the presence of no
agonist, neither set of neutrophils produced ROS (Supplemental
Figure 5), indicating that the neutrophils had not been activated
in the isolation process. However, TREM-1/3–deficient neutrophils had a 50% reduction in ROS production in response to opsonized zymosan as compared with WT neutrophils (Supplemental
Figure 5), whereas ROS production in response to PMA was intact
(Supplemental Figure 5). It is well established that neutrophils
eliminate P. aeruginosa through a number of O2-independent pathways, including bactericidal/permeability-increasing protein (BPI),
proteases, lipases, and defensins (24). In fact, neutrophils isolated
from patients with CGD (an inherited defect in NADPH oxidase

resulting in severely impaired ROS production) effectively kill
P. aeruginosa, indicating that ROS production is not required in order
to effectively kill this organism (24). Therefore, given the in vitro
killing data, the striking in vivo phenotype in the TREM-1/3–deficient mice is likely not due to an intrinsic neutrophil killing defect.
Lungs from TREM-1/3–deficient mice have decreased histologic evidence
of pneumonia. Histologic examination of lungs harvested from live
mice at 14 hours after infection showed an unexpected difference.
Lung tissue from 5 TREM-1/3–deficient animals and 5 WT animals was analyzed by a veterinary pathologist unaware of sample
identities. The degree of inflammation was quantified as described
in the Methods. TREM-1/3–deficient animals had less evidence
of inflammation/pneumonia as compared with WT animals
(Figure 4, A and B). Moreover, TREM-1/3–deficient animals had
reduced leukocyte infiltration by morphometry (P = 0.016) and
fewer necropurulent foci (P = 0.05) present in the lungs as compared with WT animals (Figure 4, C and D, respectively). Taken
together, these data indicate that, despite increased bacterial load
and higher mortality, TREM-1/3–deficient animals have impaired
pulmonary inflammation in response to P. aeruginosa challenge.
TREM-1/3–deficient animals have decreased neutrophils in the airway.
To assess leukocyte migration into the lung, first we asked whether
there was a defect in wbc translocation into the lung. Single-cell
suspension of lungs from WT and TREM-1/3–deficient animals
were prepared to quantitate total lung wbc. TREM-1/3–deficient
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Figure 6
TREM-1/3–deficient animals have intact local cytokine
and chemokine production. BAL: Indicated chemokine levels were measured in BAL fluid from WT
and TREM-1/3–deficient mice 14 hours after infection. *CXCL1/KC: P = 0.048, CCL2/MCP: P = 0.017,
and CXCL2/MIP-2: P = 0.004 (n = 27, 3 independent
experiments). Lung homogenates: Cytokine and chemokine profiles from WT and TREM-1/3–deficient lung
homogenates. *IL-1α: P = 0.038, IL-1β: P = 0.038, IL-6:
P = 0.015, IL-10: P = 0.05, IL-17: P = 0.022, TNF-α:
P = 0.007, CXCL1/KC: P = 0.02, CXCL2/MIP-2: P = 0.012,
and CCL2/MCP-1: P = 0.035 (n = 22, 2 independent
experiments). Plasma: Plasma cytokine and chemokine levels in WT and TREM-1/3–deficient mice at
14 hours after inoculation with P. aeruginosa. *G-CSF:
P = 0.0004, IL-6: P = 0.0001, IL-1α: P = 0.0448,
CCL5/RANTES: P = 0.022, TNF-α: P = 0.0072, IL-10:
P = 0.0007, CXCL1/KC: P = 0.0011, CXCL2/MIP-2:
P = 0.0018, and CCL2/MCP-1: P = 0.0002 (n = 28, 3
independent experiments). Error bars indicate SEM.
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Figure 7
TREM-1/3–deficient neutrophils undergo cell death at rates similar
to those of WT neutrophils. (A and B) WT and TREM-1/3–deficient
neutrophil cell death was measured in vitro at rest (NS, not stimulated)
and with stimulation with LPS or IFN-γ in the absence (A) or presence
(B) of FCS. Representative data, 3 independent experiments. Error
bars indicate SEM.

animals had similar numbers of eosinophils, macrophages, NK
cells, CD4+ T cells, CD8+ T cells, and B cells (Figure 5A, n = 15).
Unexpectedly, the number of total lung neutrophils was significantly higher in TREM-1/3–deficient animals (Figure 5A,
P = 0.001). Therefore, despite having more total lung neutrophils,
TREM-1/3–deficient mice failed to develop pneumonia with consolidation and were unable to clear P. aeruginosa lung infection,
resulting in a marked increase in mortality.
Next, we determined using BAL whether TREM-1/3–deficient mice
have defective neutrophil translocation into the airspace. More than
96% of all cells from the BAL fluid of both groups were Ly6G positive and CD115 negative (data not shown), consistent with murine
neutrophil identity. TREM-1/3–deficient mice had a 50% reduction
in the number of airway neutrophils (Figure 5B, P = 0.004), suggesting impaired migration of neutrophils into the airspace. We then
used a stereological approach to further localize neutrophils in the
compartments of the lung by specifically examining the interstitium,
the airway lumen (terminal bronchioles), and the alveolar space. To
assess the location of neutrophils in the distal airways, we identified
terminal bronchioles and a sequestration index was calculated to
assess the relative number of neutrophils in the interstitium versus
the distal airway lumen. Terminal bronchioles from TREM-1/3–
deficient mice had a higher sequestration index as compared with
WT mice (Figure 5C, n = 13, P = 0.001), indicating that a higher proportion of neutrophils was present in the interstitial space as compared with the lumen and suggesting a neutrophil migratory block
into the bronchiolar airway. There was no detectable difference in
the number of neutrophils in the alveolar compartment in WT and
TREM-1/3–deficient mice (Figure 5D). The features of consolidation and alveolar collapse were at times confounding issues, and it
remains unclear whether a migratory block at the alveolar level exists
in TREM-1/3–deficient mice. Taken together, the histologic data and
BAL data indicate that, with TREM-1/3 deficiency, there is a defect in
neutrophil migration into the airspace.
TREM-1/3–deficient mice have increased cytokine production both locally and systemically following P. aeruginosa challenge. Because TREM-1
acts synergistically with TLR and other PRRs to augment proinflammatory cytokine production, we hypothesized that a blunted
cytokine response to infection with P. aeruginosa would be responsible for decreased airway neutrophils in TREM-1/3–deficient
animals. Cytokines were sampled in the plasma, BAL fluid, and

total lung homogenates. To avoid survivor bias, all samples were
collected at 14 hours following infection, when all animals in both
groups were alive. First, to ascertain whether decreased neutrophil migration was the result of a deficiency in local chemokine
production, we obtained BAL fluid from infected mice. CXCL1/
KC, CXCL2/MIP-2, and CCL2/MCP were elevated in TREM-1/3–
deficient as compared with WT mice, consistent with sufficient
local production of chemoattractants (Figure 6, BAL: P = 0.048,
P = 0.017, and P = 0.004, respectively). In separate experiments,
total tissue cytokine levels were measured in lungs harvested from
anesthetized TREM-1/3–deficient and WT mice after perfusion
with PBS from the right ventricle to remove intravascular blood
(Figure 6, Lung homogenates). TREM-1/3–deficient mice had
higher levels of IL-1α (P = 0.038), IL-1β (P = 0.038), IL-6 (P = 0.015),
IL-10 (P = 0.05), IL-17 (P = 0.022), and TNF-α (P = 0.007) and
chemokines CXCL1/KC (P = 0.02), CXCL2/MIP-2 (P = 0.012),
and CCL2/MCP-1 (P = 0.035). Based on these results and those
shown in Figures 4 and 5, we conclude that despite elevated local
cytokines and chemokines, TREM-1/3–deficient animals have
ineffective accumulation of neutrophils in the airway lumen.
Additionally, systemic cytokine levels were measured (Figure 6). The
TREM-1/3–deficient mice had statistically significant increases in
the proinflammatory cytokines G-CSF, IL-6, IL-1α, CCL5/RANTES,
TNF-α, IL-12p40 (P = 0.004, data not shown), and IL12-p70 (P = 0.020,
data not shown); increased levels of chemoattractants CXCL1 /KC,
CCL2/MCP-1, CXCL2/MIP-2; and increased anti-inflammatory
cytokine IL-10. These data indicate that the cytokine production
was not impaired in the setting of infection despite the loss of the
TREM-1/3 amplifying pathway. Moreover, these data indicate that
impaired cytokine production was not responsible for the decrease
in neutrophils in the airway lumen of TREM-1/3–deficient animals.
TREM-1/3–deficient neutrophils have normal cell death. To investigate
whether the diminished number of neutrophils in the airways of
TREM-1/3–deficient animals was due to increased cell death, we
isolated neutrophils from TREM-1/3–deficient and WT animals
and determined cell death by propidium iodide uptake as previously described (25). We observed no significant difference in the
percentage of neutrophils undergoing cell death spontaneously or

Figure 8
Deficiency of TREM-1/3 does not abrogate in vitro neutrophil
chemotaxis in response to chemokines. WT and TREM-1/3–deficient
neutrophil chemotaxis was measured in response to chemoattractants
KC (5 nM, 50 nM) and 10% ZAS. The line labeled PBS indicates the
number of chemotactic neutrophils relative to the PBS control. Representative data; n = 2–3 mice pooled per group; 3 independent experiments. Error bars indicate SEM.
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Figure 9
TREM-1/3–deficient neutrophils have intact transendothelial migration.
The ability of WT and TREM-1/3–deficient neutrophils to migrate across
murine endothelial cell monolayers (SVEC4-10 cells and MBECs) and
primary murine lung endothelial cell monolayers was measured in
response to stimulation with 10% ZAS. Representative data, n = 2–3 mice
pooled per group, 3 independent experiments. Error bars indicate SEM.

in response to LPS or IFN-γ in the absence or presence of serum
(Figure 7, A and B, respectively). Therefore, impaired neutrophil
survival is likely not the mechanism of decreased neutrophil accumulation in the airways of TREM-1/3–deficient animals.
In vitro chemokine-induced migration is intact in TREM-1/3–deficient neutrophils. Next, we examined neutrophil migration using
the TX migration plate (see Methods) to determine whether the
defect in neutrophil accumulation in the airway of TREM-1/3–

deficient mice was the result of an intrinsic defect in the ability of
TREM-1/3–deficient neutrophils to respond to chemoattractants.
Neutrophils were placed in the upper compartment of chambers
separated from the lower compartment by a filter with 3-μm pores.
Zymosan-activated serum (ZAS) or CXCL-1/KC was added to the
lower chamber as a chemoattractant. There was no significant difference in migration between WT and TREM-1/3–deficient cells
(Figure 8), indicating that deficiency in TREM-1/3 does not alter
the migratory response to chemoattractants.
TREM-1/3–deficient neutrophils have intact transendothelial migration.
The first step in neutrophil migration into infected airways is neutrophil migration from the vasculature across the pulmonary capillary endothelial cell monolayer. We hypothesized that TREM-1/3
may interact with endothelial cell receptors to facilitate neutrophil
migration across the endothelial cell barrier. Therefore, we examined
whether TREM-1/3–deficient neutrophils had an impaired ability to
cross endothelial cell monolayers in vitro. Murine endothelial cells
lines (SVEC4-10 and murine brain endothelial cells [MBECs]) were
seeded on 3-μm-pore-size Transwell filters and grown to confluence.
Freshly isolated bone marrow–derived neutrophils were loaded on
the apical side of the endothelial monolayers, and ZAS (10%), a
neutrophil chemoattractant, was added to the opposite side. There
was no defect in the ability of TREM-1/3–deficient neutrophils to
migrate across murine endothelial cell monolayers as compared
with WT neutrophils (Figure 9). In addition, we repeated the experiments using primary murine endothelial cells cultured as previously
described (26). Consistent with the cell line data, we observed similar migration of TREM-1/3–deficient and WT neutrophils across
primary murine endothelial cell monolayers (Figure 9). These data
suggest that impaired transendothelial migration is not the mechanism of decreased neutrophils in the airway of TREM-1/3–deficient
mice following P. aeruginosa challenge.

Figure 10
TREM-1/3 are required for neutrophil migration across AEC monolayers. (A) TEM image the air-interface cultured primary murine airway epithelia,
including 2 ciliated cells (C). (B) TEM image of a neutrophil (N) attached to the underside of the Transwell filter prior to migration through a pore.
Brackets indicate the filter; arrowheads indicate each side of a pore. Scale bars: 2 μm. (C) Migration of WT and TREM-1/3–deficient neutrophils
across WT AECs in response to KC or PBS control was measured. *P = 0.02 vs. WT neutrophil migration to KC. (D) WT and TREM-1/3–deficient
neutrophil migration across TREM-1/3–deficient AECs was measured as in C. *P = 0.02 vs. WT neutrophil migration to KC. Representative data;
n = 3 mice pooled per group; 2 independent experiments. Error bars indicate SEM.
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TREM-1/3–deficient neutrophils have a defect in transepithelial migration.
In vivo, once neutrophils migrate from the capillaries, they must
cross a pseudo-stratified epithelium to enter the luminal side of
the airway. Airway epithelial cells (AECs) are polarized, and neutrophil transepithelial migration occurs from the basolateral side
of AEC to the apical side of AEC into the airway lumen. Therefore, the ability of TREM-1/3–deficient neutrophils to migrate
across primary polarized AECs was examined. While TREM-1
and TREM-3 are not known to be expressed on AECs, to eliminate an AEC defect in TREM-1/3–deficient mice as the source of
impaired migration, we cultured both WT and TREM-1/3–deficient primary murine tracheal AECs on Transwells using previously described methods (27). The differentiated AECs from WT
and TREM-1/3–deficient mice established transepithelial resistance greater than 500 Ω•cm2, indicating the presence of tight
junctions. Transmission electron micrograph (TEM) images of
the murine airway epithelial monolayers demonstrate ciliate cell
features (Figure 10A). Figure 10B depicts a neutrophil attached
to underside of the Transwell filter before migration. Freshly isolated bone marrow–derived neutrophils (pooled from 3 mice per
group) were loaded on the basolateral side of AECs by inversion of
the Transwells. CXCL1/KC was added as a chemoattractant to the
culture medium on the apical side of the epithelium. Migration
of WT neutrophils was similar across WT and TREM-1/3–deficient AECs (P = 0.19). By contrast, TREM-1/3–deficient neutrophils demonstrated a significant migratory defect in response to
CXCL1/KC across both WT (Figure 10C) and TREM-1/3–deficient
AECs (Figure 10D). Treatment of WT neutrophils with a TREM-1
polyclonal antibody but not a TREM-3 monoclonal antibody
decreased migration across WT AECs (data not shown). Together,
these data suggest that TREM-1 functions in neutrophil migration across AECs and that impaired neutrophil migration is the
defect responsible for the susceptibility of TREM-1/3–deficient
mice to P. aeruginosa pneumonia.
Discussion
More than 2 million people die of pneumonia annually worldwide,
most of them children under the age of 5 (28). These deaths occur
at extremes of the immune response: too much inflammation and
its associated lung injury can cause death, and insufficient inflammation and failure to clear infection can lead to the same result.
Here, we identify TREM-1 as a novel receptor required for neutrophil transepithelial migration into the airway lumen. Our data suggest a mechanism by which impaired migration results in decreased
neutrophil recruitment and ineffective bacterial clearance. Subsequently, the TREM-1–deficient animals die due to excessive cytokine
release and bacterial dissemination. Thus, potential therapeutic agents to treat pneumonia, such as TREM-1 inhibitors, must
achieve a balance between pathogen control and host tissue damage.
The neutrophil response is titrated not only through regulated
cytokine and antimicrobial product release but also via controlled
migration into the lung. Indeed, recent studies using intravital
microscopy document the complexity of neutrophil migration
(29, 30). These cells can immediately cross an endothelial cell
barrier, pause and decide not to cross, or even cross and then
reverse course to return to the vessel lumen, suggesting that the
neutrophil is capable of integrating complex environmental signals (30). Determining how neutrophil migration is influenced
by these disparate signals is critical for understanding the pathogenesis of pneumonia, acute respiratory distress syndrome, and

other inflammatory diseases of the lung. The role of TREM-1
in cytokine augmentation has been well described, and our data
demonstrate that TREM-1 is also involved in the process of neutrophil transepithelial migration.
Neutrophil migration into infected tissues has been studied
extensively (31, 32). In the systemic circulation, the initial site of
emigration is the postcapillary venule. Here, the neutrophil undergoes capture and rolling on the endothelial surface, and selectin
family members play a critical role (33–35). Once firm adhesion has
been established, transendothelial migration occurs under these
laminar flow conditions. In contrast, neutrophil migration in the
lung occurs in the pulmonary capillaries. Here a complex web of
anastomosing capillaries requires the neutrophil to deform in order
to pass through the vessels (36–38). Spatial constraints in the capillary most likely supplant the need for rolling and capture in the pulmonary circulation (39), thus providing an explanation for the fundamental difference in neutrophil migration in the lung compared
with the systemic circulation. On the pulmonary endothelium,
firm adhesion is primarily mediated by the interaction between the
β2 integrins CD18/CD11a (also LFA-1 or αLβ2) and CD18/CD11b
(also Mac-1 or αMβ2) expressed on the neutrophils and ICAM-1
(also CD54), ICAM-2, and ICAM-3 expressed on the endothelial
cell surface (40–42). Both homotypic and heterotypic interactions
between PECAM-1 (CD31), CD177, β2 integrins, ICAM-1, and
junctional adhesion molecule (JAM) family members facilitate
transendothelial migration (43–46). Because we observed decreased
neutrophil accumulation in the lung airspace in TREM-1/3–
deficient mice, we initially hypothesized that TREM-1/3 deficiency
would cause defective transendothelial migration. However, TREM1/3–deficient neutrophils migrated effectively across both murine
endothelial cell lines and primary murine endothelial cells, likely
via these previously described pathways, suggesting that TREM-1/3
is not required for transendothelial migration.
Compared with transendothelial migration, the molecular
details of transepithelial migration are less well understood,
including the extent to which neutrophils infiltrate the lung at the
level of the large airway, the small airway, and/or the alveolar epithelia. Moreover, transepithelial migration is a dynamic process,
and neutrophil passage through the alveolar interstitium is difficult to quantitate macroscopically. Our in vitro data using large
airway epithelia grown at the air-liquid interface support a defect
in neutrophil transepithelial migration. However, a limitation of
our study is that we are unable to culture alveolar epithelia at the
air-liquid interface for in vitro testing. In our model of TREM-1/3
deficiency, we detected differential compartmentalization of neutrophils in the interstitial space at the level of the small airway in
vivo, consistent with a defect in transepithelial migration.
The integrity of the airway epithelium is achieved via tight junctions and adherens junction protein interactions. Paracellular
migration is presumably achieved through alterations in tight
junction protein interactions. Neutrophil adherence to the pulmonary epithelial cell layer is mediated by β2 integrins, in particular CD18/CD11b and ICAM, though CD11a and CD11c may play
some role (47–55). The role of JAMs in intestinal transepithelial
migration has also been studied. For example, JAM C but not JAM
A has been implicated in intestinal neutrophil transepithelial
migration, with studies demonstrating that JAM C antibodies
decrease the rate of neutrophil transepithelial migration but do
not block migration (56). Recently a role for junctional adhesion
molecule–like protein (JAML), which is expressed on neutrophils,
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was described in intestinal transepithelial migration (57). JAML
binds to epithelial cell via the coxsackie and adenovirus receptor (CAR), and soluble forms of either of these molecules impede
neutrophil transepithelial migration across cultured intestinal
epithelium. CD47, which is expressed on both epithelial cells and
neutrophils, is also required for intestinal neutrophil transepithelial migration, though the mechanism is still being characterized
and no studies have been conducted in the lung epithelium (58).
To date there is no evidence for an interaction between TREM-1
and any of these adhesion molecules, suggesting that alternative
mechanisms exist by which TREM-1 mediates neutrophil adhesion and migration across epithelial cells.
In this study, we demonstrate that loss of TREM-1/3 expression results in impaired neutrophil transepithelial migration
in a murine pneumonia model. Gibot and colleagues examined
the role of TREM-1 in bacterial pneumonia using a different
approach (17). Their study involved instillation of a TREM-1–
blocking peptide, LP-17, into the rat trachea following pneumonia challenge. Interestingly, this resulted in decreased lung
inflammation and improved survival. Blockade of TREM-1–
mediated amplification of cytokine production was thought to
be the mechanism behind improved survival. However, our data
suggest that LP-17 may play a role in blocking neutrophil migration. We propose that a partial blockade of neutrophil migration
into the airways may allow a sufficient quantity of neutrophils to
clear the infection but prevent extensive lung injury by attenuating transepithelial migration.
In summary, our results implicate TREM-1 as a novel player in
neutrophil pulmonary transepithelial migration. We hypothesize
that the TREM-1 interaction with the pulmonary epithelium provides a second novel regulatory pathway in vivo for TREM-1 to
amplify inflammation through targeted migration into lung. In
the absence of TREM-1, in vivo neutrophil migration to the airway lumen is impaired. This leads to ineffective bacterial killing
and increased mortality. Further study of the role of TREM-1/3
molecules in transepithelial migration may identify therapeutic
targets to modulate neutrophil influx, thereby altering the local
inflammatory response not through classic cytokine signaling but
through controlled migratory access.
Methods
Generation of TREM-1/3–deficient mice. To abrogate expression of functional
TREM-1 and TREM-3 proteins, we made a targeting construct in which
an 8.8-kb fragment containing most of exon 3 and exon 4 of TREM-1 as
well as exon 1 of TREM-3 was replaced with an MC1neopA gene flanked
by loxP sites (Supplemental Figure 1). This effectively deleted the transmembrane region of TREM-1 in addition to the start site and first domain
of TREM-3. The targeting construct was linearized and transfected into
E14.1 (129P2/OlaHsd) ES cells. 450 clones were chosen and expanded in
duplicate; genomic DNA isolated from one set was digested with KpnI
(K) and hybridized with a 3′ external probe (B) on Southern blots (endogenous, 13.5 kb; targeted, 17.8 kb). One correctly targeted clone was identified and confirmed by Southern blot analysis using multiple digestions
and 5′ (A), 3′ (B), and Neo probes. This clone was injected into C57BL/6
blastocysts; chimeras were bred to transgenic mice expressing Cre under
the CMV promoter (59) on a C57BL/6 background to delete the MC1neopA gene (TREM-1/3 del). Transmission of the TREM-1/3 deletion in
agouti offspring was determined by PCR using tail DNA as a template
and the following oligonucleotides: TREM-1/3 28279, TCTTGCCGCTGATTGGTTCA; TREM-1/3 27096, TCCCAAGAGCAGGCACAAGA;
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TREM-1/3 19239, TCTCTCCATCTATGCATCCACCC; endogenous,
373 bp, deletion, 270 bp. Heterozygous mice were intercrossed to generate
mice homozygous for the deletion.
Speed congenics. We backcrossed the TREM-1/3 mutation onto a C57BL/6
background facilitated by genome-wide simple sequence length polymorphism (SSLP) typing at 10-cm intervals for each generation (done by the
Speed Congenics Facility supported by the Rheumatic Diseases Core Center at Washington University School of Medicine). The mice used for these
experiments were >97% C57BL/6.
C57BL/6 mice were originally purchased from NCI. All animals used in
this study were bred in a barrier facility at the University of Iowa. Mice
used in pneumonia challenge studies were littermates or WT mice bred
in our facility. The age of pneumonia experimental mice (55–75 days) was
matched in WT and TREM-1/3–deficient mice. Mice used in all other
experiments were <100 days of age.
Pneumonia models. P. aeruginosa, strain PA103, was grown overnight in LB
broth and subcultured to mid-log phase and diluted to 2 × 105 CFU/ml.
Mice were anesthetized with ketamine/xylazine, followed by intubation
with a 24G catheter, and 1 × 104 CFU P. aeruginosa was instilled into the
trachea. Mice recovered from anesthesia and were monitored for symptoms and temperature and euthanized when body temperature fell below
26°C or if they were moribund. Temperatures were determined using an
Exergen Corp. Veterinary Infrared Tympanic Temperature Scanner, Model
VTTS-1000. Survival studies were performed on separate animals. Mice in
survival studies received no additional treatments.
Plasma and tissue collection. Pneumonia was induced as before in separate
groups of mice. At 14 hours after infection, mice were anesthetized, and
blood was collected in tubes containing 10 mM EDTA. Tubes were centrifuged at 1,000 g for 10 minutes at 4°C. Supernatant plasma was aspirated
and stored in multiple aliquots at –80°C until analysis. For histology or organ
cytokine assays, lungs and liver were perfused with PBS through a catheter
placed in the right ventricle. An opening was made in the right atrium to
allow fluids to escape. Mouse lungs were hand homogenized in a buffer
containing 15 mM Tris, 0.5% Triton X-100, 150 mM NaCl, 1 mM CaCl2,
1 mM MgCl2, pH 7.4. Supernatants from homogenates were centrifuged
at 1,000 g for 10 minutes at 4°C and stored in multiple aliquots at –80°C.
Thawed lung homogenate supernatants were filtered through a 0.22-μm filter prior to analysis. For single-cell lung suspension analyses, perfused lungs
were cut into small pieces and digested in 4 ml HBSS supplemented with
60 U/ml DNase I (Sigma-Aldrich) and 125 U/ml collagenase (Invitrogen)
for 30 minutes at 37°C. Lung tissue was pressed through a wire mesh screen
(Cellector, Bellco Glass) following digestion to create a single-cell suspension.
Bone marrow–derived neutrophils. Mice were euthanized, and bone marrow
was collected from femurs and tibias. Cells were isolated on a discontinuous
Percoll gradient (MB Biomedical) composed of 81%, 62%, 55%, and 50%, and
cells between the 62% and 81% layers were collected. Red blood cells were
lysed with RBC Lysis Buffer (eBioscience) and neutrophils suspended in
HBSS, without Ca2+ and Mg2+, and held on ice prior to testing. Neutrophil
preparations were routinely >70% pure as determined by Cytospin.
Histology. At 14 hours after infection with P. aeruginosa, mice were anesthetized and perfused with 20 ml PBS and 20 ml 4% formaldehyde, and
then lungs were placed in vials containing 4% formaldehyde. Lungs were
placed under vacuum overnight, paraffin embedded, and stained with
H&E. Histologic analysis was performed by a veterinary pathologist
unaware of sample identities. Bilateral lungs from 5 animals in each group
were examined. The scoring system was as follows — for cellularity (most
severe foci assessed in lung): 1, mild, scattered leukocytes in interstitium
and airspaces; 2, moderate, scattered leukocytes forming aggregates in
interstitium and perivascular spaces and extending into airspaces; 3, moderate to severe prominent leukocyte infiltration in interstitium extending
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into airspaces often with prominent perivascular aggregates; for edema: 0,
none; 1, mild, wispy eosinophilic material detectable in rare foci; 2, mild
to moderate amounts of eosinophilic material detectable in scattered to
coalescing foci; 3, moderate to extensive amounts of eosinophilic material
filling alveoli. For necrotic foci, distinct necrotic cellular foci (often severely
degenerated neutrophils with uncommon parenchymal components) in
parenchyma were enumerated in the most severe region of each lung using
×200 magnification fields, 2 samples/slide × 2 slides (4 samples total).
Lung scoring. Right and left lungs were sectioned in the coronal plane.
Using a stereotactic approach, grids were used to segment the parenchyma
into squares, and random numbers were used to identify regions for analysis, except when anatomic-specific regions were assessed. All examination,
morphometry, and scoring were done in manner blinded to treatment
group. For bronchiole neutrophils, terminal bronchioles (TBs) were identified in sections of lung as small airways opening into alveolar ducts, and
in each TB the number of neutrophils within the lumen and those in the
submucosa (exterior to airway epithelium basement membrane) were enumerated. These were scored based on the relative proportion of neutrophils
in each TB as follows: 1, interstitial neutrophils < luminal neutrophils; 0.5,
interstitial neutrophils = luminal neutrophils; and 0, interstitial neutrophils > luminal neutrophils. For alveolar neutrophils, random sections of
lung were assessed (×400 magnification, BX51 microscope, Olympus) for
the number of neutrophils within alveoli, and these numbers were standardized as neutrophils per 100 alveoli (60).
BAL. At 14 hours after infection, mice were anesthetized, and the chest
cavity was opened. The trachea was exposed, an incision made, and tubing
inserted. The lungs were flushed with 3 × 1 ml PBS. Fluids were collected
and volumes recorded. For bacterial counts, 100 μl fluid was removed and
plated on LB agar as described below. The remaining fluid was centrifuged
to remove cells, and supernatant was stored in aliquots at –80°C.
Bacterial counts. Bacterial load was determined by dilution and plate
count on LB agar following standard microbiological methods. CFU were
counted, and CFU/ml was calculated.
Flow cytometry. Heparinized whole blood was stained, and rbc were lysed
with 150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA. BAL fluids were
centrifuged and pelleted cells resuspended in 2% FBS in PBS for staining.
BAL cells were incubated with mouse Fc Block (BD 553141) prior to additional staining. Blood and BAL were stained with anti-CD115 (eBioscience
12-1152) and anti-Ly6G (BD 551460), which is specific for Ly6G without
Ly6C cross-reactivity, per the manufacturer’s instructions. Cell type was
determined by FACS on a BD LSR II with BD FACSDiva software. For
single lung suspension analysis, a total of 2 × 106 lung cells were stained
in a 96-well round-bottom plate. Lung homogenates were surface stained
with mAbs specific to CD45, Ly6c, Ly6g, Siglec F (BD Biosciences), CD11c,
F4/80, MHC II, CD4, CD8, B220, CD19, DX5, and CD3 for 30 minutes at
4°C and fixed with FACS lysing solution (BD Biosciences) for 10 minutes
at room temperature. All monoclonal antibodies were purchased from BioLegend unless otherwise stated. Stained cells were run on a BD LSRFortessa. The total numbers of eosinophils (CD11cintSiglec F+), neutrophils
(Ly6c+Ly6ghi), macrophages (CD11c+F4/80+), NK cells (CD3+DX5+), CD4+
T cells (CD3+CD4+), CD8+ T cells (CD3+CD8+), and B cells (CD19+B220+)
were quantified using FlowJo (Tree Star) software.
Cytokine and chemokine assays. Plasma and BAL fluids were analyzed using
the Milliplex Bead Assay (Millipore). Cytokines/chemokines were all quantified using a customized multiplex magnetic bead panel kit (catalog MCYTOMAG-70K, Millipore). The manufacturer’s instructions were followed
for assay parameters and protocol, with the following minor modification:
50 μl BAL fluid was used instead of the recommended 25 μl. G-CSF levels in mice subjected to bacterial challenge were extremely high compared
with those of all other cytokines. Thus, G-CSF was not included in the

multiplex panel but assayed independently at a 20-fold dilution using the
same magnetic bead procedures. A Bio-Plex Pro II plate washer (Bio-Rad)
was used to wash magnetic beads. Fluorescence intensity was measured on
a Bio-Plex 200 system using Bio-Plex Manager software. Data collection
parameters were set to 50 beads per region, 60-second timeout, bead map
of 100 regions, sample size of 100 μl, and gate setting of 5,000–25,000.
ALT serology. ALT was determined from plasma collected as described
above using Abaxis VetScan, Prep Profile II.
Phagocytosis assay. Murine bone marrow neutrophils were isolated as previously described and held on ice in HBSS, without Ca2+ and Mg2+. Texas
red–zymosan particles (Molecular Probes, Invitrogen) were sonicated for
5 minutes, opsonized in normal mouse serum in the dark for 30 minutes at
37°C, washed, and resuspended at 0.4 M/ml in HBSS, with Ca2+ and Mg2+,
0.1% glucose, and 1% human serum albumin. 500,000 neutrophils were
mixed with opsonized Texas red–zymosan at MOI of 1, 5, and 25 in 100 μl
HBSS, with Ca2+ and Mg2+, 0.1% glucose, and 1% human serum albumin.
The mixtures were incubated at 37°C for 30 minutes, then placed on wet
ice for 5 minutes, stained with Ly6G-FITC (BD Biosciences — Pharmingen)
for 20 minutes on ice, and washed. FACs was performed on a BD LSR II
with BD FACSDiva software and analyzed using Cellquest software.
Neutrophil bacterial killing. Neutrophils were isolated from bone marrow as
described and resuspended at 6 × 105/ml in HBSS without Ca2+ and Mg2+
and held on ice. An overnight culture of P. aeruginosa strain PA103 was subcultured until OD600 was 0.6. One milliliter of culture was pelleted at 600 g
for 5 minutes. The pellet was resuspended in 1 ml HBSS with Ca2+ and Mg2+,
0.5% BSA, and 10% pooled human serum and opsonized for 20 minutes at
37°C, with rotation. Bacteria were washed twice in ice-cold PBS and resuspended in 1 ml HBSS with Ca2+ and Mg2+ and 0.5% BSA. Bacteria were diluted to 2.5 × 106/ml in HBSS with Ca2+ and Mg2+ and 0.5% BSA. Neutrophils
were mixed with bacteria at 1:1 for an MOI of 1:4 and incubated together at
37°C/5% CO2, with rotation for 45 minutes. Gentamicin sulfate (Cellgro),
0.5 mg/ml, was added, and incubation continued for 15 minutes. The mixture was washed twice in PBS to remove gentamicin and free bacteria. Neutrophils were resuspended in HBSS with Ca2+ and Mg2+ and 0.5% BSA and
returned to the incubator. Samples were taken at relevant time points, and
neutrophils were washed once in ice-cold PBS and lysed with 100 μl LB broth
plus 0.1% Triton X-100. Plate counts were made by serial dilution on LB agar.
NADPH oxidase activity. NADPH oxidase activity was determined using
Fluostar Omega (BMG Technologies). Neutrophils were isolated from bone
marrow of healthy mice as described and resuspended at 1 × 106 cells/ml
in HBSS, with Ca2+ and Mg2+, 0.1% glucose, and 0.1% human serum albumin. 200 μl of cell suspension with lucigenin (Sigma-Aldrich) at a final
concentration of 100 μM was stimulated with opsonized zymosan (OpZ)
(Molecular Probes, Invitrogen) at a ratio of 2:1 OpZ to neutrophils or
with 10 ng/ml PMA (Sigma-Aldrich). Zymosan particles were sonicated
for 5 minutes, opsonized by incubation with pooled human serum for
30 minutes at 37°C, centrifuged, and resuspended in HBSS, with Ca2+ and
Mg2+, 0.1% glucose, and 0.1% human serum albumin. Chemiluminescence
readings were taken every minute for 60 minutes and reported as relative
luminescence units per minute.
Cell death assay. 2 × 105 neutrophils resuspended in DMEM containing
10% FCS or not were cultured in tissue culture wells previously coated with
BSA (100 ng/ml BSA in PBS, 2 hours at 37°C). Cell death was determined by
the propidium iodide uptake assay of DNA content as previously described
(25). In brief, cells were resuspended in 0.5 ml PBS and then fixed by adding
1.5 ml ice-cold 70% ethanol and incubating for 1 hour at 4°C. Fixed cells
were washed once with 10 ml PBS containing 10% FCS, resuspended in the
same buffer containing 40 μg/ml RNase A, and 50 μg/ml propidium iodide
and incubated for 30 minutes in the dark. Samples were acquired by FACS,
and cell death was determined based on hypodiploid DNA content.
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TX migration plate assay. Murine bone marrow neutrophils were isolated
as previously described and stained with calcein-AM (Invitrogen, C3099)
at a final concentration of 5 μg/ml. Cells were incubated at 37°C for
30 minutes, washed, and stored in HBSS, without Ca2+ and Mg2+. Cells
were diluted to 106/ml in HBSS, with Ca2+ and Mg2+, 0.1% glucose, and 1%
human serum albumin prior to addition to the plate. ZAS was prepared
by incubating normal mouse serum with sonicated zymosan (Molecular
Probes, Invitrogen) particles at 37°C for 30 minutes (61). The zymosan
particles were removed by centrifugation, and the resulting serum was
diluted to 10% in HBSS, with Ca2+ and Mg2+, 0.1% glucose, 1% human
serum albumin. KC (R&D Systems, 1395-KC) was diluted to 50 nM and
5 nM in HBSS, with Ca2+ and Mg2+, 0.1% glucose, and 1% human serum
albumin. DPBS without Ca2+ and Mg2+ was used to determine random
migration. The TX migration plate (Neuroprobe, 101-3) consisted of a
3-μm pore filter in a 96-well format. 30 μl of stimulant or PBS was placed
in the wells below the filter. The filter was snapped in place, and 25,000
neutrophils in 25 μl droplets were placed in hydrophobic rings on the
filter, which allowed contact with the stimulant below. Additionally, a
standard curve of stained cells was prepared from both cell preparations,
and 25 μl placed in separate wells below the filter, with no fluid on the
filter top. The prepared plate was incubated for 3 hours at 37°C/5% CO2.
Following incubation, the cells were removed from the top of the filter
by gently wiping with tissues and rinsing with HBSS, without Ca2+ and
Mg2+. The plate was read on a Tecan Safire2 at 485 nm (excitation) and
530 nm (emission). The number of migrated cells was calculated from the
standard curves, based on relative fluorescence units, using Excel. Graphs
were made using GraphPad Prism.
Neutrophil migration across airway endothelial cells. SVEC4-10 murine lymph
node endothelial cells (ATCC CRL-2181) were grown in DMEM (Gibco,
Invitrogen) supplemented with 10% FBS (Hyclone) and l-glutamine (Gibco).
MBECs, a gift from Beverly Davidson (University of Iowa, Iowa City, Iowa,
USA), were grown in DMEM/F12 (Gibco), supplemented with 10% FBS
and 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco). Endothelial
cells were cultured on gelatin-coated, 3.0-μm-pore-size Transwell
filters (Costar, 3472) for 3 days at 37°C/5% CO2 with 1 ml of medium in
the bottom chamber. Confluence was assessed by H&E staining. Freshly
isolated neutrophils were diluted to 5 × 106/ml in HBSS, with Ca2+ and
Mg2+, 0.1% glucose, and 1% human serum albumin. 100 μl of neutrophil
suspension was added to the Transwell, and 1 ml of 10% ZAS/medium
was placed in the chamber below. Neutrophils migrated in the apical-tobasolateral direction for 16 hours, and then were collected from the lower
chamber and counted using a hemocytometer.
Mouse endothelial cell isolation. Murine pulmonary endothelial cells
were isolated as previously described (26). Mice were anesthetized with
ketamine/xylazine. The lungs were perfused with 10 ml of 2-mM EDTA in
PBS, followed by 5 ml 0.25% trypsin/2 mM EDTA via the right ventricle.
The lungs were removed and incubated at 37°C for 30 minutes in PBS.
The lungs were minced with a sterile blade, suspended in 2 ml DMEM
plus 10% FBS, and washed 10 times to elute cells from the lung. Cells, but
not debris, were placed in a 15-ml conical tube and centrifuged 5 minutes
at 250 g. Cells were resuspended in 1.5 ml EGB-2 medium, 2% FBS, and
supplements (EGM-2 Bullet Kit, Lonza CC3162) and plated in two 6-well
plates precoated with 0.2% gelatin/PBS. Medium was changed at 24 hours
and every other day until use.
Neutrophil migration across AECs. Mouse tracheal AECs were cultured
on 3-μm-pore-size Transwell filter (Costar, 3470) based on a previous
report (27). Two weeks after seeding, the differentiated AECs established
transepithelial resistance >500 Ω•cm2. To investigate the transepithelial
migration ability of neutrophils, freshly isolated bone marrow derived
neutrophils pooled from 3 mice per group (200,000/well) were loaded
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on the basolateral side of AECs by inverting the Transwells. KC (50 nM)
was added at the apical side of culture medium. After 16 hours of coincubation, the cells in apical medium were collected and cytospinned
on a glass microscope slide. Ly6G immunostaining was performed to
identify neutrophils. Ly6G+ cells were quantified by counting 3 random
fields under a ×20 objective lens.
TEM. Filters for TEM were processed using conventional methods. Briefly, samples were fixed in 2.5% gluteraldehyde in 0.1 M cacodylate buffer,
postfixed in 1% osmium tetroxide, and en bloc stained in 2.5% aqueous
uranyl acetate. The filters were then dehydrated in a graded series of ethanol washes, transitioned to Eponate-12 resin (Ted Pella Inc.), and cured
overnight at 65°C. Ultrathin sections were post-stained with uranyl acetate
and lead citrate and imaged in a JEOL JEM 1230 transmission electron
microscope equipped with a Gatan 2k × 2k digital camera.
Statistics. Unless otherwise noted, all data were evaluated using GraphPad Prism software. Error bars represent SEM. Statistical significance was
determined by Mann-Whitney nonparametric t test. For cytokine assays,
geometric mean fluorescence (MF) was analyzed using a 5-parameter logistic equation. Based on expected/observed concentration ratios, interpolated values greater than 10,000 pg/ml (highest concentration used for standard curve) were all arbitrarily set to 12,000 pg/ml, while values calculated
to be less than 16 pg/ml were all set to 0. In the case of G-CSF, the upper
limit was set to 240 ng/ml and the lower limit to 300 pg/ml. A statistical
software package (SAS) was used to assess differences in concentrations of
each cytokine between WT (C57BL/6) mice and TREM-1/3–deficient mice
using the nonparametric Wilcoxon test. P values less than 0.05 were considered significant. For single lung suspension analysis, statistical analyses
were performed using InStat software (GraphPad Software). Groups were
compared using 2-way ANOVA with Bonferroni post-test analyses to determine whether there was a statistical significance of at least α = 0.05.
Study approval. All protocols involving mice were approved by the University
of Iowa Institutional Animal Care and Use Committee and were carried out
in accordance with institutional guidelines and regulations. TREM-1/3–deficient animals were generated at Washington University in St. Louis with the
approval of the Washington University Animal Care and Use Committee and
were carried out in accordance with institutional guidelines and regulations.
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